FIRSEKIBART
UNII 6ZU8B6H4KT

Substance Identification & Data

This profile provides standardized clinical and technical data for Firsekibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6ZU8B6H4KT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2981430-39-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6ZU8B6H4KT
CAS Registry Number
2981430-39-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FIRSEKIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13353
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Firsekibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FIRSEKIBART

Common Names & Synonyms

FIRSEKIBART [INN]
H-GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-455) (VH (HOMO SAPIENS IGHV3-49*05 (94.0%) -(IGHD) -IGHJ6*01 (94.4%), CDRIMGT (8.10.19) (26-33.51-60.99-117)) (1-128) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10(CH1 (129-226), HINGE 1-12 S10>P (236) (227-238), CH2 L92 (317) (239-348), CH3 (349-453), CHS (454-455)) (129-455)), (142-211')-DISULFIDE WITH L-LAMBDA2 LIGHT CHAIN HOMO SAPIENS (1'-212') (V-LAMBDA (HOMO SAPIENS IGLV3-1*01 (96.8%) -IGLJ2*01 (100%), CDR-IMGT (6.3.9) (26'-31'.49'-51'.88'-96')) (1'-106') -HOMO SAPIENS IGLC2*01 (100%) (C-LAMBDA2) (107'-212')); DIMER (234-234'':237-237'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G4 (236-PROLINE), ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN MONOCLONAL GENSCI048 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GENSCI048 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-LAMBDA2, ANTI-(HOMO SAPIENS IL1B (INTERLEUKIN 1 BETA, IL-1B, 1L1F2)), HOMO SAPIENS MONOCLONAL ANTIBODY